QT prolongation through hERG K(+) channel blockade: current knowledge and strategies for the early prediction during drug development (Q33151796)

22 July 2017

1 reference

title

QT prolongation through hERG K(+) channel blockade: current knowledge and strategies for the early prediction during drug development (English)

1 reference

22 July 2017

Matteo Masetti

3

0 references

Elisabetta Poluzzi

object named as

Elisabetta Poluzzi

2

0 references

Fabrizio De Ponti

object named as

Fabrizio De Ponti

5

0 references

author name string

Maurizio Recanatini

1

1 reference

PubMed ID

15389727

22 July 2017

Andrea Cavalli

4

1 reference

22 July 2017

1 March 2005

1 reference

Medicinal Research Reviews

22 July 2017

1 reference

22 July 2017

25

1 reference

22 July 2017

2

1 reference

22 July 2017

133-166

1 reference

Mechanism of block and identification of the verapamil binding domain to HERG potassium channels

22 July 2017

1 reference

Relationship between QT interval and heart rate in Alderley Park beagles.

21 January 2018

1 reference

Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2

21 January 2018

1 reference

Molecular determinants of dofetilide block of HERG K+ channels.

21 January 2018

1 reference

A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474

21 January 2018

1 reference

Class III antiarrhythmic drugs block HERG, a human cardiac delayed rectifier K+ channel. Open-channel block by methanesulfonanilides

21 January 2018

1 reference

The Structure of the Potassium Channel: Molecular Basis of K+ Conduction and Selectivity

21 January 2018

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.280.5360.69

Identifiers

DOI

10.1002/MED.20019

1 reference

22 July 2017

1 reference

PubMed ID

15389727